Achieving Optimized Rescue Therapy for Acute Repetitive Seizures
April 30, 2026 1:00pm – 2:15pm (ET) Recorded Webinar
CE: 1.0 contact hours
This educational webinar, made possible by an educational grant from Neurelis, provides a comprehensive overview of acute repetitive seizures (ARS), including their prevalence, clinical impact and associated patient burden. Participants will explore the critical importance of early recognition and rapid intervention using evidence-based rescue therapies, with a focus on recently advanced intranasal treatment options. The program also highlights the role of collaborative, team-based care in developing individualized seizure action plans to improve patient outcomes and quality of life. Designed for the interdisciplinary care team, this session emphasizes patient-centered strategies to optimize ARS management across care settings.
-
Webinar Details
When: April 30, 2026, 1-2:15 p.m. ET (12-1:15 p.m. CT).
Where: Recorded webinar.
Cost: Free for AANP members and non-members.
About the Webinar:
This engaging educational webinar offers a comprehensive, clinically relevant exploration of ARS, equipping nurse practitioners and the broader care team with the knowledge and tools needed to optimize patient outcomes. Participants will gain a deeper understanding of ARS prevalence, risk factors and clinical consequences, while also examining the latest evidence surrounding FDA-approved rescue therapies — including emerging intranasal options — and their role in rapid seizure termination. The program emphasizes practical, patient-centered strategies such as early recognition, individualized seizure action planning and collaborative, team-based care approaches to improve quality of life and reduce morbidity and mortality. Attendees will benefit from 1.0 contact hours (CH) of continuing education (CE) credit, and both AANP members and non-members can access the activity at no cost. The webinar also includes a live Q&A session with expert faculty, providing an opportunity to ask questions and apply insights to real-world practice. In addition, downloadable resources — including the full set of slides and transcript — will be available in the AANP CE Center for ongoing reference, and the program will be accessible on demand for flexible learning. Participants who provide their email address and complete the evaluation and posttest will also have the opportunity to earn an additional 0.5 CH of CE through a case-based follow-up activity, further reinforcing key concepts and clinical application.
Objectives:
- Describe the prevalence, patient burden and clinical gravity of ARS.
- Examine the clinical imperative for prompt recognition and interruption of ARS using rescue therapies.
- Evaluate the evidence and regulatory milestones for ARS rescue therapies currently approved by the FDA — highlighting safety, efficacy and differentiated clinical utility.
- Design individualized, patient-centered ARS care plans, integrating available rescue therapies into best practice seizure action plans (SAPs) and acute seizure action plans (ASAPs).
This educational activity is supported by an independent medical educational grant from Neurelis.
-
Speakers
Lucretia Long, DNP, CANP, F-AES
Dr. Lucretia Long received her BSN, MSN and nurse practitioner certification from The Ohio State University and her doctorate in nursing practice from Duke University. She has over 25 years of experience and was promoted to clinical associate professor of neurology at The Ohio State University Wexner Medical Center's College of Medicine. She has served on a variety of committees for the American Academy of Neurology, the American Epilepsy Society and currently serves as the North American lead for the International League Against Epilepsy.
Dr. Long is an internationally invited speaker, including invitations in Dublin, Ireland; Lisbon, Portugal; and Kigali, Rwanda. She has a passion for APP mentorship and served as an active member on the task force to reduce morbidity and mortality in patients with epilepsy. Dr. Long is a faculty member for the Penry Epilepsy APP Fellowship Program and is a two-time recipient of the “Women in Medicine and Science Award.” Her academic and clinical efforts center on improving patient and care partner education — particularly in the areas of SUDEP communication — women’s issues in epilepsy and the implementation of acute seizure action plans.
Celia McIntosh, DNP, FNP-C, SCRN, CEN, CCRN
Dr. Celia McIntosh is the founder and principal consultant of McIntosh Advocacy & Consulting, where she partners with health care systems, nonprofits and public health organizations to design and implement strategic solutions that improve patient outcomes, workforce culture and system performance. Her work focuses on health equity, policy development, quality improvement and organizational transformation, with specialized expertise in integrating clinical protocols and addressing structural inequities in health care environments.
In her clinical role, Dr. McIntosh serves as a nurse practitioner and quality liaison within the neuroscience department, where she provides advanced neurological care while leading quality improvement initiatives across the service line. She plays a critical role in optimizing stroke care delivery, developing and implementing clinical protocols, improving compliance with evidence-based metrics and aligning interdisciplinary teams to enhance patient outcomes. Her work bridges bedside practice with systems-level strategy, ensuring that quality, safety and equity are embedded into neurological care processes.